Saratoga Investment (SAR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for September 25, 2025, at Eversheds Sutherland (US) LLP in New York, with stockholders of record as of July 29, 2025, eligible to vote.
Key proposals include electing two directors and ratifying the selection of Ernst & Young LLP as the independent auditor for fiscal year ending February 28, 2026.
Proxy materials and the annual report are available online, and stockholders are encouraged to vote electronically, by phone, or by mail.
Voting matters and shareholder proposals
Stockholders will vote on electing Steven M. Looney and Charles S. Whitman III as directors until 2028 and ratifying Ernst & Young LLP as the independent auditor.
The board unanimously recommends voting in favor of both proposals.
Shareholder proposals for the 2026 annual meeting must be received by April 7, 2026, and comply with SEC and bylaw requirements.
Board of directors and corporate governance
The board consists of five members, with a majority being independent as required by NYSE and the 1940 Act.
Directors are divided into three classes, each serving three-year terms; annual evaluations of board and committee effectiveness are conducted.
Steven M. Looney serves as lead independent director and presides over executive sessions.
The board met seven times in fiscal 2025, and all directors attended at least 75% of meetings.
Corporate governance documents, codes of ethics, and committee charters are available online.
Latest events from Saratoga Investment
- Adjusted NII per share up 12% to $1.05, with strong liquidity and high portfolio quality.SAR
Q1 20253 Feb 2026 - NII, NAV, and dividend per share rose, with all watchlist investments resolved and strong liquidity.SAR
Q2 202519 Jan 2026 - Adjusted NII $12.4M, 9.2% LTM ROE, strong portfolio quality, and special dividend paid.SAR
Q3 202510 Jan 2026 - NAV and NII per share up sequentially; portfolio quality and liquidity remain strong.SAR
Q3 20268 Jan 2026 - Shareholders will vote on re-electing Christian L. Oberbeck as director at the 2024 annual meeting.SAR
Proxy Filing1 Dec 2025 - NAV up 6.1% to $392.7M, monthly dividends initiated, portfolio quality remains strong.SAR
Q4 202520 Nov 2025 - Adjusted NII per share up 17.9%, strong ROE, high credit quality, and robust liquidity.SAR
Q1 202616 Nov 2025 - NAV up, ROE strong, NII down; portfolio resilient with low non-accruals and high liquidity.SAR
Q2 20268 Oct 2025